Our mission is to advice, and to make the people of the world healthier through the power of information.
Evolution of two protein kinases may hold key to unlocking highly specific cancer drugs
This is the story of Abl and Src -- two nearly identical protein kinases whose evolution may hold the key to unlocking new, highly specific cancer drugs.
No comments:
Post a Comment